eBioMedicine, 2026
Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activity

Bhandage A., Stascheit F., Preßler H. et al.

Stem Cell Research & Therapy, 2026
Endothelial–immune cells-on-chip for multiplex evaluation of drug responses through patient plasma screening

Lee K., Wee H., Teng Z. et al.

British Journal of Cancer, 2026
Circulating tumor-associated autoantibody signatures for diagnosis and prognosis in small-cell lung cancer and lung adenocarcinoma

Liu C., Fukuda E., Sagiya Y. et al.

Nature Medicine, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling

Suissa D., Fidelle M., Reich E. et al.

Journal of the American Academy of Dermatology, 2026
Ivarmacitinib is associated with rapid clinical improvement and immune remodeling in palmoplantar pustulosis: A multi-center, single-arm clinical trial

Xu Z., Chen W., Du J. et al.

Journal of Neuroinflammation, 2026
Extracellular vesicles from plasma of patients with minimal hepatic encephalopathy induce neuroinflammation and cognitive impairment in rats, which are prevented by treating the patients with rifaximin

Lopez-Gramaje A., Arenas Y., Gallego J. et al.

Nature Mental Health, 2026
Multi-omic signatures and trajectories of cardiometabolic diseases and depression

Yang G., Jiang X., Wang J. et al.

Current Issues in Molecular Biology, 2026
Exploring the Relationship Between Protein-Level Ratios (rQLTs) and Duodenal Ulcer

Tang S., Li Y., Yu X. et al.

Neurology Neuroimmunology & Neuroinflammation, 2026
Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Gallaccio G., Müller A., Wang M. et al.

iScience, 2026
Immune hyperactivity in hemodialysis patients is associated with interferon gamma-induced trained immunity

Jonkman I., Jacobs M., Helder L. et al.

Cardiovascular Research, 2026
Associations of the inflammasome-dependent cytokine IL-18 with risk of coronary heart disease

Björkbacka H., Gonçalves I., Engström G. et al.

International Journal of Cancer, 2026
Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort

Katzke V., Chen Y., Dutta S. et al.

Frontiers in Sports and Active Living, 2026
Preliminary effects of a four-month circuit training intervention on cognitive function and exploratory plasma proteomic profiles in middle-aged and older women: an open-label randomized controlled trial

Soga K., Takahashi M., Oba K. et al.

Clinical Ophthalmology, 2026
92-Plex Inflammatory Proteomic Signatures in Aqueous Humor of High Myopia and Candidate Biomarkers

Yang M., Wu W., Dong N. et al.

ACR Open Rheumatology, 2026
Colchicine Inhibits Chemokine Production in Monosodium Urate–Stimulated Innate Immune Cells

Merlo Pich L., Schlüter T., Sarlea A. et al.

Frontiers in Endocrinology, 2026
Sex specific pattern of adipose expansion, inflammation and dysfunction with short term high fat diet exposure

Skibniewska J., Desai S., Casell-Kelley L. et al.

Communications Biology, 2026
Single-cell catalogue of immune cells from Japanese individuals

Kashima Y., Makishima K., Fujii G. et al.

Archivos de Bronconeumología, 2026
Severe OSA May Be Associated With Endothelial Dysfunction in Patients With Nocturnal Hypertension

Dodani K., Puech C., Pinilla L. et al.

Biological Psychiatry Global Open Science, 2026
APOE genotypes modulate the relationship of hypertension with Alzheimer's Disease: associations and clues of peripheral mechanisms

Wu H., Hou J., Huang L. et al.

RMD Open, 2026
First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients

Meijs A., Kolmert J., Lindquist S. et al.